Merck to Begin Testing Alzheimer’s Treatment Theory

Merck & Co. announced this week plans to begin testing a possible cause of Alzheimer’s. The testing is commencing after 200 patients were reviewed for three months while taking MK-8931, an experimental Merck drug which reduces a side effect of the illness. The...

Medical Device Industry Fighting Tax to Save Jobs

In 2015, the medical device industry claimed that nearly 33,000 jobs had been lost since 2012 due to the Affordable Care Act’s device tax of 2.3%. Though former President Barak Obama signed a bill halting the tax for two years, the industry is fighting to have the tax...

Aurobindo Pharma Reveals Plans for U.S. Production

Following President Trump’s meeting with pharmaceutical executives this month, many foreign drug makers have begun planning production sites in the United States. Aurobindo Pharma, an Indian pharmaceutical company is one of these foreign drug makers interested in...

Marathon Pharmaceutical Delays DMD Drug Launch

The same day congressional voiced aired concern over Marathon’s $89,000 price of a decades-old Duchenne Muscular Disorder treatment, EMFLAZA (deflazacort), Marathon’s CEO released a statement Monday citing that the company is pausing their “commercialization efforts.”...

Incyte Acquires Right to Antibody Development from Agenus

In 2015, Incyte and Agenus both agreed to work on developing and commercializing antibodies GITR and GX40. In a statement early this week, however, the two have announced plans for Incyte to retain rights to solely develop and commercialize the drugs, profits from...

Allergan Fights Preventable Blindness

After unveiling “See America,” this week, Allergen has spoken out about its commitment to fighting preventable blindness in America. The company will be partnering with Prevent Blindness, a health organization dedicated to promoting eye-health information. The two...